A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Multiple-Dose Phase I Clinical Study to Evaluate the Safety, Tolerance, and Pharmacokinetic Profiles of Timolol Maleate Gel in Healthy Chinese Adult Subjects
Latest Information Update: 21 Feb 2025
At a glance
- Drugs Timolol (Primary)
- Indications Haemangioma
- Focus Adverse reactions
- Sponsors Auson Pharmaceuticals
Most Recent Events
- 21 Feb 2025 New trial record